Therapy Areas: Cardiovascular
Ra Medical Systems Prices US Initial Public Offering
28 September 2018 - - US-based Ra Medical Systems, Inc. (NYSE: RMED) has priced its initial public offering of 3.9m shares of common stock at a price to the public of USD 17.00 per share, the company said.

In addition, Ra Medical has granted the underwriters a 30-day option to purchase up to an additional 585,000 shares of common stock at the initial public offering price less underwriting discounts and commissions.

Ra Medical's common stock began trading on the New York Stock Exchange under the symbol "RMED" on September 27, 2018.

The offering is expected to close on October 1, 2018, subject to customary closing conditions.

Piper Jaffray and Co. and Cantor Fitzgerald and Co. are acting as lead joint book-running managers for the offering. SunTrust Robinson Humphrey, Inc. is acting as lead manager and Nomura Securities International, Inc. and Maxim Group LLC are acting as co-managers for the offering.

Ra Medical Systems was founded in 2002 to commercialise excimer lasers and catheters for the treatment of dermatologic and cardiovascular diseases.

Its flagship product, Pharos, launched in 2004.
Login
Username:

Password: